Microfluidic Devices Market By Product (Microfluidic-based Devices, Microfluidic Components), By Application (In-vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing, Therapeutics), By End User (Hospitals & Diagnostic Centers, Acade

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,840	220 Pages	Allied Market Research	July, 2022	ALMR17464601

Best Price Guarantee
Price	from $3,840
Length	220 Pages
Publisher	Allied Market Research
Published Date	July, 2022
SKU	ALMR17464601

Microfluidic Devices Market By Product (Microfluidic-based Devices, Microfluidic Components), By Application (In-vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing, Therapeutics), By End User (Hospitals & Diagnostic Centers, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2021-2031

The global microfluidic devices market was valued at $20,971.0 million in 2021, and is projected to reach $158,119.5 million by 2031, registering a CAGR of 22.4% from 2022 to 2031.

Microfluidics is the study of systems that can process small quantities of fluids by using tiny channels having dimensions at the microscale – typically tens to hundreds of micrometers. Microfluidics allows the analysis and use of less volume of samples, chemicals and reagents reducing the global fees of applications.

The increase in prevalence of various infectious diseases such as Flu A, B and diphtheria boosts the growth of the market. Microfluidics are used in the diagnostics of various infectious diseases. In addition, novel approach for the cost-effective diagnosis of tuberculosis further contributes toward the growth of the market. For instance, according to world health organization (WHO), a total of 1.5 million people died from tuberculosis in 2020 worldwide, and tuberculosis is the thirteenth leading cause of death. Thus, increase in prevalence of infectious diseases and rise in use of microfluidics for diagnosis drive the growth of the market.

Moreover, microfluidics are highly sensitive and cost effective which drives the demand for microfluidics devices in diagnosis. In addition, the microfluidics device-based diagnosis requires less quantity of sample and easy product type of operation which boosts the adoption of microfluidics in diagnosis

Furthermore, increase in prevalence of autoimmune disease such as rheumatoid arthritis, scleroderma, and lupus contributes toward the growth of the market. For instance, according to global RA network, approximately 350 million people have arthritis globally. Arthritis, or joint disease, is inflammation of one or more of the joints, such as the knees, knuckles, wrists, or ankles. Arthritis starts as joint inflammation but can progress into joint pain, swelling, and stiffness. A microfluidic chip was recently developed to detect autoimmune diseases. The device measures the number of specified antibodies in the blood.

Moreover, increase in R&D activities for development of advanced microfluidics device such as 3D printing & robotics, rise in U.S. food and drug administration (USFDA) approvals and novel product launch in the market by key players boost the market growth. For instance, in December 2020, Conformis, Inc., a leader in patient-specific knee and hip instrumentation and implants, announced today the U.S. commercial launch of the Company’s new Cordera Match Hip System. Furthermore, advancements in microfluidics devices such as robotics and navigation support further contribute toward the market growth. However, high cost of microfluidics devices and product recall are anticipated to hinder the growth of the market.

The microfluidics device market is segmented on the basis of product type, application, end user and region. By product type, the market is divided into microfluidic-based devices and microfluidic components. The microfluidic components segment is classified into microfluidic chips, flow & pressure sensors, flow & pressure controllers, microfluidic valves, micropumps, microneedles and other components.

Depending on application, the market is classified into in-vitro diagnostics, pharmaceutical & life science research & manufacturing and therapeutics. The in-vitro diagnostics segment is further classified into clinical diagnostics, point-of-care testing and veterinary diagnostics. The pharmaceutical & life science research & manufacturing and therapeutics segment is further classified into lab analytics, microdispensing and microreaction. The lab analytics segment is further categorized into proteomics, genomics, cell-based assays and capillary electrophoresis.

The therapeutics segment is further classified into drug delivery and wearable devices.

Based on end user, the market is categorized into hospitals & diagnostic centers, academic & research institutes, and pharmaceutical & biotechnology companies. By region segment, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Lonza Group, Thermo Fisher Scientific Inc., Perkinelmer Inc., Biorad Laboratories, Inc., Illumina, Inc., Qiagen N.V., Fluidigm Corporation, Dolomite Microfluidics, bioMérieux SA, Abbott Laboratories, Danaher Corporation, SMC Corporation, Idex Corporation, Fortive Corporation, Agilent Technologies, Inc., Nanostring and Nortis Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the microfluidic devices market analysis from 2021 to 2031 to identify the prevailing microfluidic devices market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the microfluidic devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global microfluidic devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Microfluidic-based Devices
Microfluidic Components
Type
Microfluidic Chips
Flow Pressure Sensors
Flow Pressure Controllers
Microfluidic Valves
Micropumps
Microneedles
Other Components

By Application

In-vitro Diagnostics
Type
Clinical Diagnostics
Point-of-care Testing
Veterinary Diagnostics
Pharmaceutical Life Science Research and Manufacturing
Type
Lab Analytics
Microdispensing
Microreaction
Therapeutics
Type
Drug Delivery
Wearable Devices

By End User

Hospitals Diagnostic Centers
Academic Research Institutes
Pharmaceutical Biotechnology Companies

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Soudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Lonza Group
Thermo Fisher Scientific Inc.
Perkinelmer Inc.
Biorad Laboratories, Inc.
Illumina, Inc.
Qiagen N.V.
Fluidigm Corporation
Dolomite Microfluidics
bioMérieux SA
Abbott Laboratories
Danaher Corporation
SMC Corporation
Idex Corporation
Fortive Corporation
Agilent Technologies, Inc.
Nanostring
Nortis Inc.

Please Note: It will take 7-10 business days to complete the report upon order confirmation.

CHAPTER 1:INTRODUCTION: 1.1.Report description; 1.2.Key market segments; 1.3.Key benefits to the stakeholders; 1.4.Research Methodology; 1.4.1.Secondary research; 1.4.2.Primary research; 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY: 2.1.Key findings of the study; 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW: 3.1.Market definition and scope; 3.2.Key findings; 3.2.1.Top investment pockets; 3.3.Porter’s five forces analysis; 3.4.Top player positioning; 3.5.Market dynamics; 3.5.1.Drivers; 3.5.2.Restraints; 3.5.3.Opportunities; 3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: MICROFLUIDIC DEVICES MARKET, BY PRODUCT: 4.1 Overview; 4.1.1 Market size and forecast; 4.2 Microfluidic-based Devices; 4.2.1 Key market trends, growth factors and opportunities; 4.2.2 Market size and forecast, by region; 4.2.3 Market analysis by country; 4.3 Microfluidic Components; 4.3.1 Key market trends, growth factors and opportunities; 4.3.2 Market size and forecast, by region; 4.3.3 Market analysis by country; 4.3.4 Microfluidic Components Microfluidic Devices Market by Type; 4.3.4.1 Microfluidic Chips Market size and forecast, by region; 4.3.4.2 Flow & Pressure Sensors Market size and forecast, by region; 4.3.4.3 Flow & Pressure Controllers Market size and forecast, by region; 4.3.4.4 Microfluidic Valves Market size and forecast, by region; 4.3.4.5 Micropumps Market size and forecast, by region; 4.3.4.6 Microneedles Market size and forecast, by region; 4.3.4.7 Other Components Market size and forecast, by region
CHAPTER 5: MICROFLUIDIC DEVICES MARKET, BY APPLICATION: 5.1 Overview; 5.1.1 Market size and forecast; 5.2 In-vitro Diagnostics; 5.2.1 Key market trends, growth factors and opportunities; 5.2.2 Market size and forecast, by region; 5.2.3 Market analysis by country; 5.2.4 In-vitro Diagnostics Microfluidic Devices Market by Type; 5.2.4.1 Clinical Diagnostics Market size and forecast, by region; 5.2.4.2 Point-of-care Testing Market size and forecast, by region; 5.2.4.3 Veterinary Diagnostics Market size and forecast, by region; 5.3 Pharmaceutical & Life Science Research and Manufacturing; 5.3.1 Key market trends, growth factors and opportunities; 5.3.2 Market size and forecast, by region; 5.3.3 Market analysis by country; 5.3.4 Pharmaceutical & Life Science Research and Manufacturing Microfluidic Devices Market by Type; 5.3.4.1 Lab Analytics Market size and forecast, by region; 5.3.4.2 Microdispensing Market size and forecast, by region; 5.3.4.3 Microreaction Market size and forecast, by region; 5.4 Therapeutics; 5.4.1 Key market trends, growth factors and opportunities; 5.4.2 Market size and forecast, by region; 5.4.3 Market analysis by country; 5.4.4 Therapeutics Microfluidic Devices Market by Type; 5.4.4.1 Drug Delivery Market size and forecast, by region; 5.4.4.2 Wearable Devices Market size and forecast, by region
CHAPTER 6: MICROFLUIDIC DEVICES MARKET, BY END USER: 6.1 Overview; 6.1.1 Market size and forecast; 6.2 Hospitals & Diagnostic Centers; 6.2.1 Key market trends, growth factors and opportunities; 6.2.2 Market size and forecast, by region; 6.2.3 Market analysis by country; 6.3 Academic & Research Institutes; 6.3.1 Key market trends, growth factors and opportunities; 6.3.2 Market size and forecast, by region; 6.3.3 Market analysis by country; 6.4 Pharmaceutical & Biotechnology Companies; 6.4.1 Key market trends, growth factors and opportunities; 6.4.2 Market size and forecast, by region; 6.4.3 Market analysis by country
CHAPTER 7: MICROFLUIDIC DEVICES MARKET, BY REGION: 7.1 Overview; 7.1.1 Market size and forecast; 7.2 North America; 7.2.1 Key trends and opportunities; 7.2.2 North America Market size and forecast, by Product; 7.2.2.1 North America Microfluidic Components Microfluidic Devices Market by Type; 7.2.3 North America Market size and forecast, by Application; 7.2.3.1 North America In-vitro Diagnostics Microfluidic Devices Market by Type; 7.2.3.2 North America Pharmaceutical & Life Science Research and Manufacturing Microfluidic Devices Market by Type; 7.2.3.3 North America Therapeutics Microfluidic Devices Market by Type; 7.2.4 North America Market size and forecast, by End User; 7.2.5 North America Market size and forecast, by country; 7.2.5.1 U.S.; 7.2.5.1.1 Market size and forecast, by Product; 7.2.5.1.2 Market size and forecast, by Application; 7.2.5.1.3 Market size and forecast, by End User; 7.2.5.2 Canada; 7.2.5.2.1 Market size and forecast, by Product; 7.2.5.2.2 Market size and forecast, by Application; 7.2.5.2.3 Market size and forecast, by End User; 7.2.5.3 Mexico; 7.2.5.3.1 Market size and forecast, by Product; 7.2.5.3.2 Market size and forecast, by Application; 7.2.5.3.3 Market size and forecast, by End User; 7.3 Europe; 7.3.1 Key trends and opportunities; 7.3.2 Europe Market size and forecast, by Product; 7.3.2.1 Europe Microfluidic Components Microfluidic Devices Market by Type; 7.3.3 Europe Market size and forecast, by Application; 7.3.3.1 Europe In-vitro Diagnostics Microfluidic Devices Market by Type; 7.3.3.2 Europe Pharmaceutical & Life Science Research and Manufacturing Microfluidic Devices Market by Type; 7.3.3.3 Europe Therapeutics Microfluidic Devices Market by Type; 7.3.4 Europe Market size and forecast, by End User; 7.3.5 Europe Market size and forecast, by country; 7.3.5.1 Germany; 7.3.5.1.1 Market size and forecast, by Product; 7.3.5.1.2 Market size and forecast, by Application; 7.3.5.1.3 Market size and forecast, by End User; 7.3.5.2 France; 7.3.5.2.1 Market size and forecast, by Product; 7.3.5.2.2 Market size and forecast, by Application; 7.3.5.2.3 Market size and forecast, by End User; 7.3.5.3 UK; 7.3.5.3.1 Market size and forecast, by Product; 7.3.5.3.2 Market size and forecast, by Application; 7.3.5.3.3 Market size and forecast, by End User; 7.3.5.4 Italy; 7.3.5.4.1 Market size and forecast, by Product; 7.3.5.4.2 Market size and forecast, by Application; 7.3.5.4.3 Market size and forecast, by End User; 7.3.5.5 Spain; 7.3.5.5.1 Market size and forecast, by Product; 7.3.5.5.2 Market size and forecast, by Application; 7.3.5.5.3 Market size and forecast, by End User; 7.3.5.6 Rest of Europe; 7.3.5.6.1 Market size and forecast, by Product; 7.3.5.6.2 Market size and forecast, by Application; 7.3.5.6.3 Market size and forecast, by End User; 7.4 Asia-Pacific; 7.4.1 Key trends and opportunities; 7.4.2 Asia-Pacific Market size and forecast, by Product; 7.4.2.1 Asia-Pacific Microfluidic Components Microfluidic Devices Market by Type; 7.4.3 Asia-Pacific Market size and forecast, by Application; 7.4.3.1 Asia-Pacific In-vitro Diagnostics Microfluidic Devices Market by Type; 7.4.3.2 Asia-Pacific Pharmaceutical & Life Science Research and Manufacturing Microfluidic Devices Market by Type; 7.4.3.3 Asia-Pacific Therapeutics Microfluidic Devices Market by Type; 7.4.4 Asia-Pacific Market size and forecast, by End User; 7.4.5 Asia-Pacific Market size and forecast, by country; 7.4.5.1 China; 7.4.5.1.1 Market size and forecast, by Product; 7.4.5.1.2 Market size and forecast, by Application; 7.4.5.1.3 Market size and forecast, by End User; 7.4.5.2 Japan; 7.4.5.2.1 Market size and forecast, by Product; 7.4.5.2.2 Market size and forecast, by Application; 7.4.5.2.3 Market size and forecast, by End User; 7.4.5.3 India; 7.4.5.3.1 Market size and forecast, by Product; 7.4.5.3.2 Market size and forecast, by Application; 7.4.5.3.3 Market size and forecast, by End User; 7.4.5.4 Australia; 7.4.5.4.1 Market size and forecast, by Product; 7.4.5.4.2 Market size and forecast, by Application; 7.4.5.4.3 Market size and forecast, by End User; 7.4.5.5 South Korea; 7.4.5.5.1 Market size and forecast, by Product; 7.4.5.5.2 Market size and forecast, by Application; 7.4.5.5.3 Market size and forecast, by End User; 7.4.5.6 Rest of Asia-Pacific; 7.4.5.6.1 Market size and forecast, by Product; 7.4.5.6.2 Market size and forecast, by Application; 7.4.5.6.3 Market size and forecast, by End User; 7.5 LAMEA; 7.5.1 Key trends and opportunities; 7.5.2 LAMEA Market size and forecast, by Product; 7.5.2.1 LAMEA Microfluidic Components Microfluidic Devices Market by Type; 7.5.3 LAMEA Market size and forecast, by Application; 7.5.3.1 LAMEA In-vitro Diagnostics Microfluidic Devices Market by Type; 7.5.3.2 LAMEA Pharmaceutical & Life Science Research and Manufacturing Microfluidic Devices Market by Type; 7.5.3.3 LAMEA Therapeutics Microfluidic Devices Market by Type; 7.5.4 LAMEA Market size and forecast, by End User; 7.5.5 LAMEA Market size and forecast, by country; 7.5.5.1 Brazil; 7.5.5.1.1 Market size and forecast, by Product; 7.5.5.1.2 Market size and forecast, by Application; 7.5.5.1.3 Market size and forecast, by End User; 7.5.5.2 Soudi Arabia; 7.5.5.2.1 Market size and forecast, by Product; 7.5.5.2.2 Market size and forecast, by Application; 7.5.5.2.3 Market size and forecast, by End User; 7.5.5.3 South Africa; 7.5.5.3.1 Market size and forecast, by Product; 7.5.5.3.2 Market size and forecast, by Application; 7.5.5.3.3 Market size and forecast, by End User; 7.5.5.4 Rest of LAMEA; 7.5.5.4.1 Market size and forecast, by Product; 7.5.5.4.2 Market size and forecast, by Application; 7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE: 8.1. Introduction; 8.2. Top winning strategies; 8.3. Product Mapping of Top 10 Player; 8.4. Competitive Dashboard; 8.5. Competitive Heatmap; 8.6. Key developments
CHAPTER 9: COMPANY PROFILES: 9.1 Lonza Group; 9.1.1 Company overview; 9.1.2 Company snapshot; 9.1.3 Operating business segments; 9.1.4 Product portfolio; 9.1.5 Business performance; 9.1.6 Key strategic moves and developments; 9.2 Thermo Fisher Scientific Inc.; 9.2.1 Company overview; 9.2.2 Company snapshot; 9.2.3 Operating business segments; 9.2.4 Product portfolio; 9.2.5 Business performance; 9.2.6 Key strategic moves and developments; 9.3 Perkinelmer Inc.; 9.3.1 Company overview; 9.3.2 Company snapshot; 9.3.3 Operating business segments; 9.3.4 Product portfolio; 9.3.5 Business performance; 9.3.6 Key strategic moves and developments; 9.4 Biorad Laboratories, Inc.; 9.4.1 Company overview; 9.4.2 Company snapshot; 9.4.3 Operating business segments; 9.4.4 Product portfolio; 9.4.5 Business performance; 9.4.6 Key strategic moves and developments; 9.5 Illumina, Inc.; 9.5.1 Company overview; 9.5.2 Company snapshot; 9.5.3 Operating business segments; 9.5.4 Product portfolio; 9.5.5 Business performance; 9.5.6 Key strategic moves and developments; 9.6 Qiagen N.V.; 9.6.1 Company overview; 9.6.2 Company snapshot; 9.6.3 Operating business segments; 9.6.4 Product portfolio; 9.6.5 Business performance; 9.6.6 Key strategic moves and developments; 9.7 Fluidigm Corporation; 9.7.1 Company overview; 9.7.2 Company snapshot; 9.7.3 Operating business segments; 9.7.4 Product portfolio; 9.7.5 Business performance; 9.7.6 Key strategic moves and developments; 9.8 Dolomite Microfluidics; 9.8.1 Company overview; 9.8.2 Company snapshot; 9.8.3 Operating business segments; 9.8.4 Product portfolio; 9.8.5 Business performance; 9.8.6 Key strategic moves and developments; 9.9 bioMérieux SA; 9.9.1 Company overview; 9.9.2 Company snapshot; 9.9.3 Operating business segments; 9.9.4 Product portfolio; 9.9.5 Business performance; 9.9.6 Key strategic moves and developments; 9.10 Abbott Laboratories; 9.10.1 Company overview; 9.10.2 Company snapshot; 9.10.3 Operating business segments; 9.10.4 Product portfolio; 9.10.5 Business performance; 9.10.6 Key strategic moves and developments; 9.11 Danaher Corporation; 9.11.1 Company overview; 9.11.2 Company snapshot; 9.11.3 Operating business segments; 9.11.4 Product portfolio; 9.11.5 Business performance; 9.11.6 Key strategic moves and developments; 9.12 SMC Corporation; 9.12.1 Company overview; 9.12.2 Company snapshot; 9.12.3 Operating business segments; 9.12.4 Product portfolio; 9.12.5 Business performance; 9.12.6 Key strategic moves and developments; 9.13 Idex Corporation; 9.13.1 Company overview; 9.13.2 Company snapshot; 9.13.3 Operating business segments; 9.13.4 Product portfolio; 9.13.5 Business performance; 9.13.6 Key strategic moves and developments; 9.14 Fortive Corporation; 9.14.1 Company overview; 9.14.2 Company snapshot; 9.14.3 Operating business segments; 9.14.4 Product portfolio; 9.14.5 Business performance; 9.14.6 Key strategic moves and developments; 9.15 Agilent Technologies, Inc.; 9.15.1 Company overview; 9.15.2 Company snapshot; 9.15.3 Operating business segments; 9.15.4 Product portfolio; 9.15.5 Business performance; 9.15.6 Key strategic moves and developments; 9.16 Nanostring; 9.16.1 Company overview; 9.16.2 Company snapshot; 9.16.3 Operating business segments; 9.16.4 Product portfolio; 9.16.5 Business performance; 9.16.6 Key strategic moves and developments; 9.17 Nortis Inc.; 9.17.1 Company overview; 9.17.2 Company snapshot; 9.17.3 Operating business segments; 9.17.4 Product portfolio; 9.17.5 Business performance; 9.17.6 Key strategic moves and developments
LIST OF TABLES: TABLE 1. GLOBAL MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 2. MICROFLUIDIC DEVICES MARKET SIZE, FOR MICROFLUIDIC-BASED DEVICES, BY REGION, 2021-2031 ($MILLION); TABLE 3. MICROFLUIDIC DEVICES MARKET FOR MICROFLUIDIC-BASED DEVICES, BY COUNTRY, 2021-2031 ($MILLION); TABLE 4. MICROFLUIDIC DEVICES MARKET SIZE, FOR MICROFLUIDIC COMPONENTS, BY REGION, 2021-2031 ($MILLION); TABLE 5. MICROFLUIDIC DEVICES MARKET FOR MICROFLUIDIC COMPONENTS, BY COUNTRY, 2021-2031 ($MILLION); TABLE 6. GLOBAL MICROFLUIDIC COMPONENTS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 7. MICROFLUIDIC DEVICES MARKET, FOR MICROFLUIDIC CHIPS, BY REGION, 2021-2031 ($MILLION); TABLE 8. MICROFLUIDIC DEVICES MARKET, FOR FLOW & PRESSURE SENSORS, BY REGION, 2021-2031 ($MILLION); TABLE 9. MICROFLUIDIC DEVICES MARKET, FOR FLOW & PRESSURE CONTROLLERS, BY REGION, 2021-2031 ($MILLION); TABLE 10. MICROFLUIDIC DEVICES MARKET, FOR MICROFLUIDIC VALVES, BY REGION, 2021-2031 ($MILLION); TABLE 11. MICROFLUIDIC DEVICES MARKET, FOR MICROPUMPS, BY REGION, 2021-2031 ($MILLION); TABLE 12. MICROFLUIDIC DEVICES MARKET, FOR MICRONEEDLES, BY REGION, 2021-2031 ($MILLION); TABLE 13. MICROFLUIDIC DEVICES MARKET, FOR OTHER COMPONENTS, BY REGION, 2021-2031 ($MILLION); TABLE 14. GLOBAL MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 15. MICROFLUIDIC DEVICES MARKET SIZE, FOR IN-VITRO DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION); TABLE 16. MICROFLUIDIC DEVICES MARKET FOR IN-VITRO DIAGNOSTICS, BY COUNTRY, 2021-2031 ($MILLION); TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 18. MICROFLUIDIC DEVICES MARKET, FOR CLINICAL DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION); TABLE 19. MICROFLUIDIC DEVICES MARKET, FOR POINT-OF-CARE TESTING, BY REGION, 2021-2031 ($MILLION); TABLE 20. MICROFLUIDIC DEVICES MARKET, FOR VETERINARY DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION); TABLE 21. MICROFLUIDIC DEVICES MARKET SIZE, FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY REGION, 2021-2031 ($MILLION); TABLE 22. MICROFLUIDIC DEVICES MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY COUNTRY, 2021-2031 ($MILLION); TABLE 23. GLOBAL PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 24. MICROFLUIDIC DEVICES MARKET, FOR LAB ANALYTICS, BY REGION, 2021-2031 ($MILLION); TABLE 25. MICROFLUIDIC DEVICES MARKET, FOR MICRODISPENSING, BY REGION, 2021-2031 ($MILLION); TABLE 26. MICROFLUIDIC DEVICES MARKET, FOR MICROREACTION, BY REGION, 2021-2031 ($MILLION); TABLE 27. MICROFLUIDIC DEVICES MARKET SIZE, FOR THERAPEUTICS, BY REGION, 2021-2031 ($MILLION); TABLE 28. MICROFLUIDIC DEVICES MARKET FOR THERAPEUTICS, BY COUNTRY, 2021-2031 ($MILLION); TABLE 29. GLOBAL THERAPEUTICS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 30. MICROFLUIDIC DEVICES MARKET, FOR DRUG DELIVERY, BY REGION, 2021-2031 ($MILLION); TABLE 31. MICROFLUIDIC DEVICES MARKET, FOR WEARABLE DEVICES, BY REGION, 2021-2031 ($MILLION); TABLE 32. GLOBAL MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 33. MICROFLUIDIC DEVICES MARKET SIZE, FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021-2031 ($MILLION); TABLE 34. MICROFLUIDIC DEVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2031 ($MILLION); TABLE 35. MICROFLUIDIC DEVICES MARKET SIZE, FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION); TABLE 36. MICROFLUIDIC DEVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION); TABLE 37. MICROFLUIDIC DEVICES MARKET SIZE, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2031 ($MILLION); TABLE 38. MICROFLUIDIC DEVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2031 ($MILLION); TABLE 39. MICROFLUIDIC DEVICES MARKET, BY REGION, 2021-2031 ($MILLION); TABLE 40. NORTH AMERICA MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 41. NORTH AMERICA MICROFLUIDIC COMPONENTS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 42. NORTH AMERICA MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 43. NORTH AMERICA IN-VITRO DIAGNOSTICS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 44. NORTH AMERICA PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 45. NORTH AMERICA THERAPEUTICS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 46. NORTH AMERICA MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 47. NORTH AMERICA MICROFLUIDIC DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION); TABLE 48. U.S. MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 49. U.S. MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 50. U.S. MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 51. CANADA MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 52. CANADA MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 53. CANADA MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 54. MEXICO MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 55. MEXICO MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 56. MEXICO MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 57. EUROPE MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 58. EUROPE MICROFLUIDIC COMPONENTS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 59. EUROPE MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 60. EUROPE IN-VITRO DIAGNOSTICS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 61. EUROPE PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 62. EUROPE THERAPEUTICS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 63. EUROPE MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 64. EUROPE MICROFLUIDIC DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION); TABLE 65. GERMANY MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 66. GERMANY MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 67. GERMANY MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 68. FRANCE MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 69. FRANCE MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 70. FRANCE MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 71. UK MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 72. UK MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 73. UK MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 74. ITALY MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 75. ITALY MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 76. ITALY MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 77. SPAIN MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 78. SPAIN MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 79. SPAIN MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 80. REST OF EUROPE MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 81. REST OF EUROPE MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 82. REST OF EUROPE MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 83. ASIA-PACIFIC MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 84. ASIA-PACIFIC MICROFLUIDIC COMPONENTS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 85. ASIA-PACIFIC MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 86. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 87. ASIA-PACIFIC PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 88. ASIA-PACIFIC THERAPEUTICS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 89. ASIA-PACIFIC MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 90. ASIA-PACIFIC MICROFLUIDIC DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION); TABLE 91. CHINA MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 92. CHINA MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 93. CHINA MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 94. JAPAN MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 95. JAPAN MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 96. JAPAN MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 97. INDIA MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 98. INDIA MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 99. INDIA MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 100. AUSTRALIA MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 101. AUSTRALIA MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 102. AUSTRALIA MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 103. SOUTH KOREA MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 104. SOUTH KOREA MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 105. SOUTH KOREA MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 106. REST OF ASIA-PACIFIC MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 107. REST OF ASIA-PACIFIC MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 108. REST OF ASIA-PACIFIC MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 109. LAMEA MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 110. LAMEA MICROFLUIDIC COMPONENTS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 111. LAMEA MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 112. LAMEA IN-VITRO DIAGNOSTICS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 113. LAMEA PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 114. LAMEA THERAPEUTICS MICROFLUIDIC DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 115. LAMEA MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 116. LAMEA MICROFLUIDIC DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION); TABLE 117. BRAZIL MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 118. BRAZIL MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 119. BRAZIL MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 120. SOUDI ARABIA MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 121. SOUDI ARABIA MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 122. SOUDI ARABIA MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 123. SOUTH AFRICA MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 124. SOUTH AFRICA MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 125. SOUTH AFRICA MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 126. REST OF LAMEA MICROFLUIDIC DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 127. REST OF LAMEA MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION); TABLE 128. REST OF LAMEA MICROFLUIDIC DEVICES MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 129.LONZA GROUP: COMPANY SNAPSHOT; TABLE 130.LONZA GROUP: OPERATING SEGMENTS; TABLE 131.LONZA GROUP: PRODUCT PORTFOLIO; TABLE 132.LONZA GROUP: NET SALES,; TABLE 133.LONZA GROUP: KEY STRATERGIES; TABLE 134.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT; TABLE 135.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS; TABLE 136.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO; TABLE 137.THERMO FISHER SCIENTIFIC INC.: NET SALES,; TABLE 138.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES; TABLE 139.PERKINELMER INC.: COMPANY SNAPSHOT; TABLE 140.PERKINELMER INC.: OPERATING SEGMENTS; TABLE 141.PERKINELMER INC.: PRODUCT PORTFOLIO; TABLE 142.PERKINELMER INC.: NET SALES,; TABLE 143.PERKINELMER INC.: KEY STRATERGIES; TABLE 144.BIORAD LABORATORIES, INC.: COMPANY SNAPSHOT; TABLE 145.BIORAD LABORATORIES, INC.: OPERATING SEGMENTS; TABLE 146.BIORAD LABORATORIES, INC.: PRODUCT PORTFOLIO; TABLE 147.BIORAD LABORATORIES, INC.: NET SALES,; TABLE 148.BIORAD LABORATORIES, INC.: KEY STRATERGIES; TABLE 149.ILLUMINA, INC.: COMPANY SNAPSHOT; TABLE 150.ILLUMINA, INC.: OPERATING SEGMENTS; TABLE 151.ILLUMINA, INC.: PRODUCT PORTFOLIO; TABLE 152.ILLUMINA, INC.: NET SALES,; TABLE 153.ILLUMINA, INC.: KEY STRATERGIES; TABLE 154.QIAGEN N.V.: COMPANY SNAPSHOT; TABLE 155.QIAGEN N.V.: OPERATING SEGMENTS; TABLE 156.QIAGEN N.V.: PRODUCT PORTFOLIO; TABLE 157.QIAGEN N.V.: NET SALES,; TABLE 158.QIAGEN N.V.: KEY STRATERGIES; TABLE 159.FLUIDIGM CORPORATION: COMPANY SNAPSHOT; TABLE 160.FLUIDIGM CORPORATION: OPERATING SEGMENTS; TABLE 161.FLUIDIGM CORPORATION: PRODUCT PORTFOLIO; TABLE 162.FLUIDIGM CORPORATION: NET SALES,; TABLE 163.FLUIDIGM CORPORATION: KEY STRATERGIES; TABLE 164.DOLOMITE MICROFLUIDICS: COMPANY SNAPSHOT; TABLE 165.DOLOMITE MICROFLUIDICS: OPERATING SEGMENTS; TABLE 166.DOLOMITE MICROFLUIDICS: PRODUCT PORTFOLIO; TABLE 167.DOLOMITE MICROFLUIDICS: NET SALES,; TABLE 168.DOLOMITE MICROFLUIDICS: KEY STRATERGIES; TABLE 169.BIOMÉRIEUX SA: COMPANY SNAPSHOT; TABLE 170.BIOMÉRIEUX SA: OPERATING SEGMENTS; TABLE 171.BIOMÉRIEUX SA: PRODUCT PORTFOLIO; TABLE 172.BIOMÉRIEUX SA: NET SALES,; TABLE 173.BIOMÉRIEUX SA: KEY STRATERGIES; TABLE 174.ABBOTT LABORATORIES: COMPANY SNAPSHOT; TABLE 175.ABBOTT LABORATORIES: OPERATING SEGMENTS; TABLE 176.ABBOTT LABORATORIES: PRODUCT PORTFOLIO; TABLE 177.ABBOTT LABORATORIES: NET SALES,; TABLE 178.ABBOTT LABORATORIES: KEY STRATERGIES; TABLE 179.DANAHER CORPORATION: COMPANY SNAPSHOT; TABLE 180.DANAHER CORPORATION: OPERATING SEGMENTS; TABLE 181.DANAHER CORPORATION: PRODUCT PORTFOLIO; TABLE 182.DANAHER CORPORATION: NET SALES,; TABLE 183.DANAHER CORPORATION: KEY STRATERGIES; TABLE 184.SMC CORPORATION: COMPANY SNAPSHOT; TABLE 185.SMC CORPORATION: OPERATING SEGMENTS; TABLE 186.SMC CORPORATION: PRODUCT PORTFOLIO; TABLE 187.SMC CORPORATION: NET SALES,; TABLE 188.SMC CORPORATION: KEY STRATERGIES; TABLE 189.IDEX CORPORATION: COMPANY SNAPSHOT; TABLE 190.IDEX CORPORATION: OPERATING SEGMENTS; TABLE 191.IDEX CORPORATION: PRODUCT PORTFOLIO; TABLE 192.IDEX CORPORATION: NET SALES,; TABLE 193.IDEX CORPORATION: KEY STRATERGIES; TABLE 194.FORTIVE CORPORATION: COMPANY SNAPSHOT; TABLE 195.FORTIVE CORPORATION: OPERATING SEGMENTS; TABLE 196.FORTIVE CORPORATION: PRODUCT PORTFOLIO; TABLE 197.FORTIVE CORPORATION: NET SALES,; TABLE 198.FORTIVE CORPORATION: KEY STRATERGIES; TABLE 199.AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
LIST OF FIGURES: FIGURE 1.MICROFLUIDIC DEVICES MARKET SEGMENTATION; FIGURE 2.MICROFLUIDIC DEVICES MARKET,2021-2031; FIGURE 3.MICROFLUIDIC DEVICES MARKET,2021-2031; FIGURE 4. TOP INVESTMENT POCKETS, BY REGION; FIGURE 5.PORTER FIVE-1; FIGURE 6.PORTER FIVE-2; FIGURE 7.PORTER FIVE-3; FIGURE 8.PORTER FIVE-4; FIGURE 9.PORTER FIVE-5; FIGURE 10.TOP PLAYER POSITIONING; FIGURE 11.MICROFLUIDIC DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES; FIGURE 12.MICROFLUIDIC DEVICES MARKET,BY PRODUCT,2021(%); FIGURE 13.COMPARATIVE SHARE ANALYSIS OF MICROFLUIDIC-BASED DEVICES MICROFLUIDIC DEVICES MARKET,2021-2031(%); FIGURE 14.COMPARATIVE SHARE ANALYSIS OF MICROFLUIDIC COMPONENTS MICROFLUIDIC DEVICES MARKET,2021-2031(%); FIGURE 15.MICROFLUIDIC DEVICES MARKET,BY APPLICATION,2021(%)